| 2289218 | BW368_H | Body weight QTL 368 (human) | | .0185 | Body fat amount | percent fat | 20 | 1 | 13559334 | Human |
| 2316328 | GLUCO237_H | Glucose level QTL 237 (human) | | | Glucose level | | 20 | 1 | 13559334 | Human |
| 2301809 | PRSTS436_H | Prostate tumor susceptibility QTL 436 (human) | | .15 | Prostate tumor susceptibility | | 20 | 1 | 13655267 | Human |
| 2292964 | PRSTS150_H | Prostate tumor susceptibility QTL 150 (human) | 5.13 | .000055 | Prostate tumor susceptibility | | 20 | 1 | 13655267 | Human |
| 1357298 | AASTH25_H | Allergic/atopic asthma related QTL 25 (human) | 1.07 | | Reversible airflow obstruction | post-bronchodilator FEV1 | 20 | 1 | 16465530 | Human |
| 2301808 | PRSTS435_H | Prostate tumor susceptibility QTL 435 (human) | | .037 | Prostate tumor susceptibility | | 20 | 1 | 16947114 | Human |
| 2293434 | PRSTS208_H | Prostate tumor susceptibility QTL 208 (human) | 1.02 | | Prostate tumor susceptibility | | 20 | 1 | 16947114 | Human |
| 2316059 | GLUCO213_H | Glucose level QTL 213 (human) | | .04 | Glucose level | | 20 | 1 | 16947114 | Human |
| 2316060 | GLUCO212_H | Glucose level QTL 212 (human) | | .013 | Glucose level | | 20 | 1 | 16947114 | Human |
| 1559359 | BW39_H | Body weight QTL 39 (human) | 3.55 | .00016 | Body weight | body mass index | 20 | 1 | 17506357 | Human |
| 2292801 | MYI35_H | Myocardial infarction susceptibility QTL 35 (human) | | | Myocardial infarction susceptibility | early-onset | 20 | 1 | 17506357 | Human |
| 2292814 | MYI36_H | Myocardial infarction susceptibility QTL 36 (human) | | | Myocardial infarction susceptibility | early-onset | 20 | 1 | 17506357 | Human |
| 1559361 | BW40_H | Body weight QTL 40 (human) | 4.08 | .000046 | Body weight | body mass index | 20 | 1 | 21862009 | Human |
| 2289620 | BW488_H | Body weight QTL 488 (human) | 1.51 | | Body fat amount | none | 20 | 1 | 21862009 | Human |
| 2289599 | BW479_H | Body weight QTL 479 (human) | 1 | | Body fat amount | none | 20 | 1 | 24173953 | Human |
| 2301806 | PRSTS437_H | Prostate tumor susceptibility QTL 437 (human) | | .13 | Prostate tumor susceptibility | | 20 | 1 | 24523882 | Human |
| 2301810 | PRSTS434_H | Prostate tumor susceptibility QTL 434 (human) | | .029 | Prostate tumor susceptibility | | 20 | 1 | 24523882 | Human |
| 2316725 | GLUCO287_H | Glucose level QTL 287 (human) | 1.86 | .00312 | Glucose level | | 20 | 1 | 24523882 | Human |
| 1643060 | BW123_H | Body Weight QTL 123 (human) | 2.46 | .00038 | Body weight | | 20 | 1 | 25584381 | Human |
| 2289553 | BP95_H | Blood pressure QTL 95 (human) | | | Blood pressure | systolic | 20 | 1 | 25584381 | Human |
| 1578598 | SCL126_H | Serum cholesterol level QTL 126 (human) | 1.7 | | Lipid level | triglyceride-HDL ratio | 20 | 559258 | 49561921 | Human |
| 2314748 | GLUCO93_H | Glucose level QTL 93 (human) | .59 | .015 | Glucose level | non-insulin dependent | 20 | 2276302 | 28276302 | Human |